MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast to Evaluate Remestemcel-L in COVID-19 Lung Disease, page-128

  1. 30,316 Posts.
    lightbulb Created with Sketch. 1834
    I wonder where @madamswer, @aatisket, @Fruitbat2 and others are?

    Quietly accumulating? They've certainly given up talking it down.

    All this 'waiting for sustainable commercialisation' shtick...suddenly silent.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.